AstraZeneca Pharma India Limited — Others, 14-03-2025: Trading Window

AstraZeneca Pharma India Limited has announced a closure of the trading window for its equity shares, effective from March 16, 2025. The window will remain closed until 48 hours post the declaration of the financial results for the quarter and half-year ending March 31, 2025. This measure is part of the company’s compliance with insider trading regulations. Investors should be aware of this temporary halt in trading, which may affect liquidity, but the anticipated financial results could provide opportunities for informed trading once the window reopens, leading to a potentially positive outlook for share movement.